Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124045853 | 12404585 | 3 | F | 20160406 | 20160628 | 20160525 | 20160711 | EXP | MY-PFIZER INC-2016249792 | PFIZER | 60.00 | YR | M | Y | 71.80000 | KG | 20160711 | MD | MY | ID |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124045853 | 12404585 | 1 | SS | BLINDED BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 1080 MG, CYCLIC | 0 | 1080 | MG | SOLUTION FOR INFUSION | |||||||
124045853 | 12404585 | 2 | SS | BLINDED BEVACIZUMAB | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | 1080 MG, CYCLIC | 0 | 1080 | MG | SOLUTION FOR INFUSION | |||||||
124045853 | 12404585 | 3 | SS | BLINDED PF-06439535 | INVESTIGATIONAL PRODUCT | 1 | Intravenous (not otherwise specified) | 1080 MG, CYCLIC | 0 | 1080 | MG | SOLUTION FOR INFUSION | |||||||
124045853 | 12404585 | 4 | SS | BLINDED PF-06439535 | INVESTIGATIONAL PRODUCT | 1 | Intravenous (not otherwise specified) | 1080 MG, CYCLIC | 0 | 1080 | MG | SOLUTION FOR INFUSION | |||||||
124045853 | 12404585 | 5 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 666.0 MG, UNK | Y | 76517 | 666 | MG | |||||||
124045853 | 12404585 | 6 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 363.0 MG, UNK | Y | 76131 | 363 | MG | |||||||
124045853 | 12404585 | 7 | C | DIAMICRON | GLICLAZIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124045853 | 12404585 | 1 | Lung neoplasm malignant |
124045853 | 12404585 | 2 | Lung neoplasm malignant |
124045853 | 12404585 | 3 | Lung neoplasm malignant |
124045853 | 12404585 | 4 | Lung neoplasm malignant |
124045853 | 12404585 | 5 | Lung neoplasm malignant |
124045853 | 12404585 | 6 | Lung neoplasm malignant |
124045853 | 12404585 | 7 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124045853 | 12404585 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124045853 | 12404585 | Anaemia | |
124045853 | 12404585 | Asthenia | |
124045853 | 12404585 | Hyponatraemia | |
124045853 | 12404585 | Leukopenia | |
124045853 | 12404585 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124045853 | 12404585 | 1 | 20160128 | 0 | ||
124045853 | 12404585 | 2 | 20160128 | 0 | ||
124045853 | 12404585 | 3 | 20160128 | 0 | ||
124045853 | 12404585 | 4 | 20160128 | 0 | ||
124045853 | 12404585 | 5 | 20160128 | 20160520 | 0 | |
124045853 | 12404585 | 6 | 20160128 | 20160520 | 0 |